Granules India Limited (NSE:GRANULES)
India · Delayed Price · Currency is INR 560.85
-5.55 (-0.98%)
At close: Dec 5, 2025
Granules India Market Cap
Granules India has a market cap or net worth of 136.05 billion as of December 5, 2025. Its market cap has increased by 6.07% in one year.
Market Cap
136.05B
Enterprise Value
147.93B
Revenue
48.42B
Ranking
n/a
PE Ratio
26.53
Stock Price
560.85
Market Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 136.05B, an increase of 83,010.66%. That is a compound annual growth rate of 34.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 136.05B | -5.12% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | 87.22B | 178.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.36T |
| Divi's Laboratories | 1.72T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.04T |
| Zydus Lifesciences | 941.58B |
| Mankind Pharma | 910.67B |
| Aurobindo Pharma | 710.38B |
| Alkem Laboratories | 676.62B |